We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

EU Directives

Summary

Questions concerned delays, processing order and possible changes to lipoedema reimbursement applications under the Cross Border Healthcare Directive; the Minister referred them to the HSE.

128. Deputy Eoghan Kenny asked the Minister for Health whether applications for reimbursement under the Cross Border Healthcare Directive are processed strictly in chronological order according to their date of receipt; if not, the circumstances in which applications may be processed out of sequence; and to explain how applications for other procedures submitted in 2026 have been processed and reimbursed while some lipoedema applications submitted in 2025 and early 2026 remain outstanding. [77974/26]

Comment on this

129. Deputy Eoghan Kenny asked the Minister for Health the number of applications for reimbursement relating to lipoedema treatment under the Cross Border Healthcare Directive that are currently outstanding, broken down by month of receipt from October 2025 to date; the number currently awaiting administrative processing, clinical review or clinical advice respectively; the number processed and reimbursed during the same period; and the current average and longest processing time for such applications. [77973/26]

Comment on this

130. Deputy Eoghan Kenny asked the Minister for Health the reason any change to the processing, clinical review or eligibility requirements for lipoedema applications under the Cross Border Healthcare Directive was not communicated to patients in advance, having regard to the written commitment issued by the National Director of HSE National Services and Schemes on 29 August 2025 that advance notice and published guidance would be provided for future changes to CBD processes and that a fair and reasonable transition period would apply. [77972/26]

Comment on this

131. Deputy Eoghan Kenny asked the Minister for Health whether applications for reimbursement for lipoedema treatment under the Cross Border Healthcare Directive have been placed on hold, delayed or otherwise prevented from progressing pending clinical review or clinical advice; if so, the date on which this commenced; the reason for the decision; and the number of applications affected and the anticipated timeframe for resolving the matter. [77971/26]

Comment on this

132. Deputy Eoghan Kenny asked the Minister for Health whether there has been any change since 29 August 2025 to the assessment, processing or reimbursement of applications relating to the treatment of lipoedema under the Cross Border Healthcare Directive; whether standard applications for treatment of the limbs under the Z01B code are now routinely being referred for clinical review; the date on which any such change was introduced; the person or body that authorised the change; and if she will make a statement on the matter. [77970/26]

Comment on this

I propose to take Questions Nos. 128, 129, 130, 131 and 132 together.

As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Comment on this